Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Preterm mortality and morbidity over 25 years.

R W I Cooke1

  • 1School of Reproductive and Developmental Medicine, University of Liverpool, Neonatal Unit, Liverpool Women's Hospital, Liverpool L8 7SS, UK. mc19@liv.ac.uk

Archives of Disease in Childhood. Fetal and Neonatal Edition
|June 23, 2006
PubMed
Summary

Neonatal survival improvements are masked by changing preterm infant variables. Key interventions like antenatal steroids and surfactant reduced mortality but increased chronic lung disease and other morbidities.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Are there critical periods for brain growth in children born preterm?

Archives of disease in childhood. Fetal and neonatal edition·2005
Same author

Prevalence of severe fatigue in primary care.

Archives of disease in childhood·2005
Same author

Perinatal and postnatal factors in very preterm infants and subsequent cognitive and motor abilities.

Archives of disease in childhood. Fetal and neonatal edition·2004
Same author

Antibiotic regimens for suspected early neonatal sepsis.

The Cochrane database of systematic reviews·2004
Same author

Ophthalmic impairment at 7 years of age in children born very preterm.

Archives of disease in childhood. Fetal and neonatal edition·2004
Same author

Health, lifestyle, and quality of life for young adults born very preterm.

Archives of disease in childhood·2004

Area of Science:

  • Neonatal medicine
  • Perinatal research
  • Pediatric critical care

Background:

  • Neonatal survival rates have improved, yet the impact of evolving preterm infant demographics is not fully understood.
  • Advances in obstetric and neonatal care have altered the landscape of preterm birth outcomes.
  • Understanding the net effect of these changes on neonatal morbidity and mortality is crucial.

Purpose of the Study:

  • To investigate how changes in the preterm population and medical interventions have influenced neonatal survival and morbidity trends.
  • To quantify the impact of specific interventions on key neonatal outcomes.
  • To provide a nuanced understanding of modern neonatal care effectiveness.

Main Methods:

  • Analysis of longitudinal data on preterm infants.

Related Experiment Videos

  • Statistical modeling to adjust for changing population variables.
  • Assessment of the association between interventions (antenatal steroids, caesarean section, surfactant) and outcomes (mortality, periventricular haemorrhage, chronic lung disease, persistent duct, septicaemia).

    • Main Results:

    • Improvements in neonatal survival have been obscured by shifts in preterm population characteristics.
    • Antenatal steroids, caesarean section, and surfactant use were associated with a one-third reduction in mortality and periventricular haemorrhage.
    • The same interventions doubled the likelihood of chronic lung disease, persistent ductus arteriosus, and septicaemia.

    Conclusions:

    • While key interventions have reduced mortality and severe brain injury in preterm infants, they have also led to an increase in other significant morbidities.
    • The evolving preterm population necessitates continuous re-evaluation of neonatal care strategies.
    • Balancing the benefits and risks of interventions is essential for optimizing long-term outcomes in preterm survivors.